Evaluation of the effects of cognitive stimulation therapy on cognitive status and apathy in older adults with mild cognitive impairment: A randomized controlled trial
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Cognitive Stimulation Therapy significantly improved cognitive function and reduced apathy in older adults with mild cognitive impairment. This therapy is recommended for geriatric care to enhance cognitive status and well-being.
Area Of Science
- Geriatric Medicine
- Neuroscience
- Psychiatry
Background
- Mild cognitive impairment (MCI) affects older adults, often leading to apathy and cognitive decline.
- Early intervention is crucial for managing MCI and improving quality of life in the elderly.
- Cognitive Stimulation Therapy (CST) is a non-pharmacological approach with potential benefits for cognitive health.
Purpose Of The Study
- To evaluate the efficacy of Cognitive Stimulation Therapy (CST) in improving cognitive status.
- To assess the impact of CST on reducing apathy levels in older adults diagnosed with MCI.
- To provide evidence-based recommendations for integrating CST into geriatric psychiatric nursing care.
Main Methods
- A randomized controlled trial was conducted with 62 older adults diagnosed with MCI.
- Participants were divided into an intervention group (receiving CST) and a control group.
- Cognitive function was assessed using the Standardized Mini-Mental State Examination (SMMSE), and apathy was measured by the Apathy Rating Scale (ARS).
Main Results
- The intervention group showed significantly higher post-test SMMSE scores (24.3 ± 1.3) compared to the control group (19.6 ± 1.5).
- The intervention group also achieved significantly higher scores on the Alzheimer's Disease Assessment Scale-Cognitive Subscale (ARS) (47.5 ± 3.5) versus the control group (36.2 ± 3.0).
- Statistical analysis indicated a significant improvement in the intervention group (p < 0.001).
Conclusions
- Cognitive Stimulation Therapy is an effective intervention for enhancing cognitive functions in older adults with MCI.
- CST demonstrates significant efficacy in reducing apathy levels among individuals with mild cognitive impairment.
- Psychiatric nurses are encouraged to implement CST as a valuable therapeutic strategy in geriatric care settings.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
Cognitive therapy, pioneered by Aaron T. Beck in the 1960s, is a structured approach to addressing psychological distress by focusing on the influence of thoughts on emotions and behaviors. All cognitive therapies involve the basic assumption that human beings have control over their feelings, and that how individuals feel about something depends on how they think about it. Unlike psychoanalytic methods that delve into unconscious processes or humanistic approaches emphasizing...
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...